Biogen Idec (BIIB)
Q2 2012 Earnings Call
July 24, 2012 8:00 am ET
ExecutivesWendy GabelGeorge A. Scangos - Chief Executive Officer and DirectorDouglas Edward Williams - Executive Vice President of Research and DevelopmentTony Kingsley - Executive Vice President of Global Commercial OperationsPaul J. Clancy - Chief Financial Officer and Executive Vice President of FinanceAlfred Sandrock - Head of Neurology Research & DevelopmentAnalystsBrian Corey Abrahams - Wells Fargo Securities, LLC, Research DivisionGeoffrey C. Porges - Sanford C. Bernstein & Co., LLC., Research DivisionMatthew Roden - UBS Investment Bank, Research DivisionMarshall Urist - Morgan Stanley, Research DivisionNavdeep Singh - Deutsche Bank AG, Research DivisionRachel L. McMinn - BofA Merrill Lynch, Research DivisionMark J. Schoenebaum - ISI Group Inc., Research DivisionEric Schmidt - Cowen and Company, LLC, Research DivisionGeoffrey C. Meacham - JP Morgan Chase & Co, Research DivisionYaron Werber - Citigroup Inc, Research DivisionRavi Mehrotra - Crédit Suisse AG, Research DivisionMichael J. Yee - RBC Capital Markets, LLC, Research DivisionCharles Anthony Butler - Barclays Capital, Research DivisionThomas Wei - Jefferies & Company, Inc., Research DivisionM. Ian Somaiya - Piper Jaffray Companies, Research DivisionPresentationOperator
Previous Statements by BIIB
» Biogen Idec's CEO Hosts 2012 Analyst Day (Transcript)
» Biogen Idec's CEO Discusses Q1 2012 Results - Earnings Call Transcript
» Biogen Idec's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV